There Is A Quest For Clarity Surrounding Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Volatility

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Teva Reports Growth in Fourth Quarter and Full Year 2023.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Stocks Info

This NYSE-listed company operates within the Drug Manufacturers – Specialty & Generic industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $12.28 and fluctuated between $12.43 as its day high and $12.03 as its day low. The current market capitalization of Teva- Pharmaceutical Industries Ltd. ADR is $13.76B. A total of 11.79 million shares were traded on the day, compared to an average of 10.01M shares.

Insider Activity

Insider trades can also provide insight into a stock’s future direction. During the recent three months, TEVA has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 2 SELLs from insiders. Insiders purchased 0 shares during that period but sold 77,421.

In the most recent transaction, Kalif Eliyahu Sharon sold 35,125 shares of TEVA for 9.73 per share on Aug 07. After the transaction, the EVP, Chief Financial Officer now owns 99,162 company shares. In a previous transaction on Aug 04, Weiss Amir sold 1,981 shares at 9.92 per share. TEVA shares that Chief Accounting Officer owns now total 42,442.

Among the insiders who sold shares, Hughes Eric A disposed of 52,742 shares on Aug 01 at a per-share price of $8.30. This resulted in the See “Remarks” holding 0 shares of TEVA after the transaction. In another insider transaction, Dethlefs Sven sold 58,066 shares at $9.43 per share on Mar 07. Company shares held by the EVP, North America Commercial now total 165,381.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for TEVA in the last 3 months, the mean price target is $49.00 with high estimates of $58.20 and low estimates of $38.72. In terms of 52-week highs and lows, TEVA has a high of $12.64 and a low of $7.09.

As of this writing, TEVA has an earnings estimate of $Enviva Inc. per share for the current quarter. EPS was calculated based on a consensus of Teva Pharmaceutical Industries estimates, with a high estimate of $CEVA, Inc. per share and a lower estimate of $Aeva Technologies, Inc.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. TEVA’s latest balance sheet shows that the firm has $2.17B in Cash & Short Term Investments as of fiscal 2021. There were $23.46B in debt and $11.03B in liabilities at the time. Its Book Value Per Share was $6.18, while its Total Shareholder’s Equity was $11.24B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TEVA is Buy with a score of 3.89.

Most Popular

Related Posts